Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
- DOI
- 10.3324/haematol.2021.278697
- Published
- 2021-07-01
- Container
- Haematologica
- Publisher
- Ferrata Storti Foundation (Haematologica)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2021.278697,
title = {Therapeutic potential of ruxolitinib and ponatinib in patients with \<i\>EPOR\</i\>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia},
author = {Lisa M Niswander and Joseph P Loftus and Élodie Lainey and Aurélie Caye-Eude and Morgane Pondrom and David A Hottman and Ilaria Iacobucci and Charles G Mullighan and Nitin Jain and Marina Konopleva and Hélène Cavé and André Baruchel and Pierre S Rohrlich and Sarah K Tasian},
year = {2021},
journal = {Haematologica},
doi = {10.3324/haematol.2021.278697},
url = {https://doi.org/10.3324/haematol.2021.278697}
}RIS
TY - JOUR TI - Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia AU - Lisa M Niswander AU - Joseph P Loftus AU - Élodie Lainey AU - Aurélie Caye-Eude AU - Morgane Pondrom AU - David A Hottman AU - Ilaria Iacobucci AU - Charles G Mullighan AU - Nitin Jain AU - Marina Konopleva AU - Hélène Cavé AU - André Baruchel AU - Pierre S Rohrlich AU - Sarah K Tasian PY - 2021 JO - Haematologica DO - 10.3324/haematol.2021.278697 UR - https://doi.org/10.3324/haematol.2021.278697 ER -
APA
Niswander, L. M., Loftus, J. P., Lainey, É., Caye-Eude, A., Pondrom, M., Hottman, D. A., Iacobucci, I., Mullighan, C. G., Jain, N., Konopleva, M., Cavé, H., Baruchel, A., Rohrlich, P. S., & Tasian, S. K. (2021). Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica. https://doi.org/10.3324/haematol.2021.278697
Source records
- crossref · retrieved 2026-09-27T04:46:17.731Z